跳至主要内容
临床试验/NCT05594069
NCT05594069已完成不适用

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients: a Randomized Controlled Trial

Peking University1 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2022年11月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
87
试验地点
1
主要终点
Critical weight loss

研究概览

简要总结

To evaluate the intervention effect of triple pre-rehabilitation on head and neck cancer patients with radiotherapy, and process evaluation to further optimize the intervention program.

The pre-rehabilitation intervention was develped previously based on the process of evidence-based-nursing, including interventions of nurtrtion, exercise, and psychology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18≤ age < 75 years old
  • The pathological diagnosis of HNC included nasopharyngeal cancer, oral cancer, oropharyngeal cancer, hypopharyngeal cancer, laryngeal cancer, salivary gland cancer;
  • Plan to receive radiotherapy
  • Basic communication skills
  • Volunteer to participate in this study.

排除标准

  • Combined with other malignant tumors
  • Distant metastasis
  • Inability to measure body composition, such as metal in the body or inability to stand alone
  • With contraindications to exercise (such as cardiovascular and cerebrovascular diseases, respiratory diseases, etc)
  • Complicated with severe liver and kidney function damage
  • Previous diagnosis of other cancers
  • pregnant or lactation women.

结局指标

主要结局

Critical weight loss

时间窗: About 6 weeks

Weight loss over 5% during radiotherapy

次要结局

  • Body composition measured by Bioelectrical Impedance Analysis (BIA)(About 6 weeks)
  • Rate of adverse reactions of radiotherapy assessed by CTCAE v5.0(About 6 weeks)
  • Patients in the intervention group were interviewed about the compliance of the study(About 6 weeks)
  • Intake assessed by a simple diet self-assessment tool (SDSAT)(About 6 weeks)
  • Number of participants with intervention-related adverse events(About 6 weeks)
  • Physical performance(About 6 weeks)
  • Quality of life of patients assessed by QLQ-C30(About 6 weeks)
  • Patients in the intervention group were interviewed about the experience of the study(About 6 weeks)
  • Psychological status assessed by hospital anxiety and depression scale (HADS)(About 6 weeks)

研究者

发起方
Peking University
申办方类型
Other
责任方
Principal Investigator
主要研究者

luqian@bjmu.edu.cn

professor

Peking University

研究点 (1)

Loading locations...

相似试验